BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1868450)

  • 1. Structure and expression of the c-sis gene and its relationship to sporadic meningiomas.
    Smidt M; Dumanski JP; Collins VP; Ratner L
    Cancer Res; 1991 Aug; 51(16):4295-8. PubMed ID: 1868450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of Alu sequences in the fifth c-sis intron in individuals with meningiomas.
    Smidt M; Kirsch I; Ratner L
    J Clin Invest; 1990 Oct; 86(4):1151-7. PubMed ID: 2212004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and expression of human c-Ha-ras and c-sis sequences in NIH3T3 transformants.
    Weismanová E; Sabová L
    Neoplasma; 1990; 37(6):675-85. PubMed ID: 2274086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J; Barbey S; Nezelof C
    Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-sis/platelet-derived growth factor-B promoter requirements for induction during the 12-O-tetradecanoylphorbol-13-acetate-mediated megakaryoblastic differentiation of K562 human erythroleukemia cells.
    Kujoth GC; Fahl WE
    Cell Growth Differ; 1997 Sep; 8(9):963-77. PubMed ID: 9300179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic AMP blocks expression of the c-sis gene in tumor cells.
    Harsh GR; Kavanaugh WM; Starksen NF; Williams LT
    Oncogene Res; 1989; 4(1):65-73. PubMed ID: 2541392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the promoter region of the c-yes proto-oncogene: the importance of the GC boxes on its promoter activity.
    Matsuzawa Y; Semba K; Kawamura-Tsuzuku J; Sudo T; Ishii S; Toyoshima K; Yamamoto T
    Oncogene; 1991 Sep; 6(9):1561-7. PubMed ID: 1923523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the human platelet-derived growth factor B-chain gene.
    Takimoto Y; Kuramoto A
    Hiroshima J Med Sci; 1993 Dec; 42(4):137-42. PubMed ID: 8014064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of c-sis and c-fos genes in human meningiomas and neurinomas.
    Riva P; Larizza L
    Int J Cancer; 1992 Jul; 51(6):873-7. PubMed ID: 1353485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and functional characterization of the chicken c-ros promoter.
    Chen J; Tong J; Tanaka-Sukegawa I; Wang LH
    Cell Growth Differ; 1995 Dec; 6(12):1523-30. PubMed ID: 9019157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal developing rat brain expresses a platelet-derived growth factor B chain (c-sis) mRNA truncated at the 5' end.
    Sasahara M; Amano S; Sato H; Yang JG; Hayase Y; Kaneko M; Sato I; Suzaki M; Hazama F
    Oncogene; 1998 Mar; 16(12):1571-8. PubMed ID: 9569024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-erbB3 gene encodes secreted as well as transmembrane receptor tyrosine kinase.
    Katoh M; Yazaki Y; Sugimura T; Terada M
    Biochem Biophys Res Commun; 1993 May; 192(3):1189-97. PubMed ID: 7685162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of the expression of c-sis mRNA in human glioblastoma cells by phorbol ester and transforming growth factor beta 1.
    Press RD; Misra A; Gillaspy G; Samols D; Goldthwait DA
    Cancer Res; 1989 Jun; 49(11):2914-20. PubMed ID: 2655888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of platelet-derived growth factor A- and B-chain/c-sis mRNA by tumor necrosis factor and other agents in adenocarcinoma cells.
    Kalthoff H; Roeder C; Humburg I; Thiele HG; Greten H; Schmiegel W
    Oncogene; 1991 Jun; 6(6):1015-21. PubMed ID: 1906154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of the SIS proximal element and its activating factors: regulated transcription of the c-SIS/PDGF-B gene in human erythroleukemia cells.
    Liang Y; Robinson DF; Kujoth GC; Fahl WE
    Oncogene; 1996 Aug; 13(4):863-71. PubMed ID: 8761308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a second promoter in the human c-myb proto-oncogene.
    Jacobs SM; Gorse KM; Westin EH
    Oncogene; 1994 Jan; 9(1):227-35. PubMed ID: 8302584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of c-sis (PDGF B-chain) and PDGF A-chain genes in ten human malignant mesothelioma cell lines derived from primary and metastatic tumors.
    Versnel MA; Hagemeijer A; Bouts MJ; van der Kwast TH; Hoogsteden HC
    Oncogene; 1988 Jun; 2(6):601-5. PubMed ID: 3290807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of ETS family members is important for the function of the c-sis/platelet-derived growth factor-B TATA neighboring sequence in 12-O-tetradecanoylphorbol-13-acetate-treated K562 cells.
    Kujoth GC; Robinson DF; Fahl WE
    Cell Growth Differ; 1998 Jul; 9(7):523-34. PubMed ID: 9690620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of PDGF-2 homodimers in human tumor cells.
    Igarashi H; Rao CD; Siroff M; Leal F; Robbins KC; Aaronson SA
    Oncogene; 1987 Mar; 1(1):79-85. PubMed ID: 3325876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl2 and ROS1 expression in human meningiomas: an analysis with respect to histological subtype.
    Girish V; Sachdeva N; Minz RW; Radotra B; Mathuria SN; Arora SK
    Indian J Pathol Microbiol; 2005 Jul; 48(3):325-30. PubMed ID: 16761743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.